Report Detail
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Insights, Forecast to 2025
- RnM2953980 |
- 16 February, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Drugs for Vancomycin-Resistant Enterococcus Faecium market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drugs for Vancomycin-Resistant Enterococcus Faecium market based on company, product type, end user and key regions.
This report studies the global market size of Drugs for Vancomycin-Resistant Enterococcus Faecium in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Vancomycin-Resistant Enterococcus Faecium in these regions.
This research report categorizes the global Drugs for Vancomycin-Resistant Enterococcus Faecium market by top players/brands, region, type and end user. This report also studies the global Drugs for Vancomycin-Resistant Enterococcus Faecium market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix
Market size by Product
Daptomycin
Linezolid
Quinupristin/dalfopristin
Ampicillin
Chloramphenicol
Others
Market size by End User
Hospital
Clinic
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Drugs for Vancomycin-Resistant Enterococcus Faecium market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drugs for Vancomycin-Resistant Enterococcus Faecium market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drugs for Vancomycin-Resistant Enterococcus Faecium companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drugs for Vancomycin-Resistant Enterococcus Faecium submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Drugs for Vancomycin-Resistant Enterococcus Faecium are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs for Vancomycin-Resistant Enterococcus Faecium market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate by Product
- 1.4.2 Daptomycin
- 1.4.3 Linezolid
- 1.4.4 Quinupristin/dalfopristin
- 1.4.5 Ampicillin
- 1.4.6 Chloramphenicol
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size
- 2.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue 2014-2025
- 2.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales 2014-2025
- 2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Growth Rate by Regions
- 2.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Regions
- 2.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Manufacturers
- 3.1.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Manufacturers
- 3.1.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Manufacturers
- 3.1.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Concentration Ratio (CR5 and HHI)
- 3.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Manufacturers
- 3.2.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Manufacturers (2014-2019)
- 3.2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Manufacturers (2014-2019)
- 3.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Manufacturers
- 3.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturing Base Distribution, Product Types
- 3.4.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type
- 3.4.3 Date of International Manufacturers Enter into Drugs for Vancomycin-Resistant Enterococcus Faecium Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Product
- 4.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Product
- 4.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Breakdown Data by End User
6 North America
- 6.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium by Countries
- 6.1.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries
- 6.1.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium by Product
- 6.3 North America Drugs for Vancomycin-Resistant Enterococcus Faecium by End User
7 Europe
- 7.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium by Countries
- 7.1.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries
- 7.1.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium by Product
- 7.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium by End User
8 Asia Pacific
- 8.1 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium by Countries
- 8.1.1 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries
- 8.1.2 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium by Product
- 8.3 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium by End User
9 Central & South America
- 9.1 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium by Countries
- 9.1.1 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries
- 9.1.2 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium by Product
- 9.3 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium by Countries
- 10.1.1 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Countries
- 10.1.2 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium by Product
- 10.3 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium by End User
11 Company Profiles
- 11.1 Alchemia Limited
- 11.1.1 Alchemia Limited Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.1.5 Alchemia Limited Recent Development
- 11.2 Alvogen
- 11.2.1 Alvogen Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.2.5 Alvogen Recent Development
- 11.3 Aphios Corporation
- 11.3.1 Aphios Corporation Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.3.5 Aphios Corporation Recent Development
- 11.4 Cellceutix Corporation
- 11.4.1 Cellceutix Corporation Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.4.5 Cellceutix Corporation Recent Development
- 11.5 Enanta Pharmaceuticals
- 11.5.1 Enanta Pharmaceuticals Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.5.5 Enanta Pharmaceuticals Recent Development
- 11.6 Helix BioMedix
- 11.6.1 Helix BioMedix Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.6.5 Helix BioMedix Recent Development
- 11.7 LegoChem Biosciences
- 11.7.1 LegoChem Biosciences Company Details
- 11.7.2 Company Business Overview
- 11.7.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.7.5 LegoChem Biosciences Recent Development
- 11.8 Lytix Biopharma
- 11.8.1 Lytix Biopharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.8.5 Lytix Biopharma Recent Development
- 11.9 MGB Biopharma Limited
- 11.9.1 MGB Biopharma Limited Company Details
- 11.9.2 Company Business Overview
- 11.9.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.9.5 MGB Biopharma Limited Recent Development
- 11.10 Microbiotix
- 11.10.1 Microbiotix Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Products Offered
- 11.10.5 Microbiotix Recent Development
12 Future Forecast
- 12.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by Regions
- 12.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Regions 2019-2025
- 12.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Regions 2019-2025
- 12.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by Product
- 12.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Product 2019-2025
- 12.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Forecast by Product 2019-2025
- 12.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by End User
- 12.4 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast
- 12.5 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast
- 12.6 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast
- 12.7 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast
- 12.8 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Drugs for Vancomycin-Resistant Enterococcus Faecium . Industry analysis & Market Report on Drugs for Vancomycin-Resistant Enterococcus Faecium is a syndicated market report, published as Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Drugs for Vancomycin-Resistant Enterococcus Faecium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
